Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
44 th Annual Meeting<br />
and ToxExpo<br />
<strong>Program</strong> Description<br />
MONDAY<br />
#115 CHARACTERIZATION OF FUNCTIONAL<br />
VARIATION IN HUMAN GSTM3 IN GLIOMA<br />
CELLS USING RNAI. X. Liu, M. R. Campbell, G. S.<br />
Pittman and D. A. Bell. Molecular genetics, NIEHS,<br />
Research Triangle Park, NC.<br />
#116 DIFFERENTIAL GENE EXPRESSION IN F344<br />
RATS FOLLOWING EXPOSURE TO EITHER<br />
POLYBROMINATED DIPHENYL ETHERS<br />
(PBDES) OR PCBs. J. M. Sanders 1,2 , L. T. Burka 1 and<br />
M. L. Cunningham 1 . 1 Laboratory <strong>of</strong> Pharmacology and<br />
Chemistry, NIEHS, Research Triangle Park, NC and<br />
2 Department <strong>of</strong> <strong>Toxicology</strong>, NC State University,<br />
Raleigh, NC.<br />
#117 EXTRACTION OF GENES WITH STABLE<br />
EXPRESSION IN RAT LIVER TREATED WITH<br />
VARIOUS COMPOUNDS–ANALYSIS OF THE<br />
DATA IN THE TOXICOGENOMICS PROJECT IN<br />
JAPAN -. H. UEDA, T. KASAHARA, H. TOTSUKA,<br />
T. MIYAGISHIMA, T. URUSHIDANI and T. NAGAO.<br />
Toxicogenomics Project, National Institute <strong>of</strong> Health<br />
Science, Setagayaku, Tokyo, Japan. Sponsor: T.<br />
INOUE.<br />
#118 CHARACTERIZATION OF AN ACUTE<br />
MOLECULAR MARKER OF NON-GENOTOXIC<br />
HEPATOCARCINOGENESIS IN RODENTS BY<br />
GENE EXPRESSION PROFILING IN A LONG-<br />
TERM CLOFIBRIC ACID STUDY. C. Michel 1 , C.<br />
Desdouets 2 , R. A. Roberts 1,3 , K. R. Isaacs 4 and E.<br />
Boitier 1 . 1 Drug Safety Evaluation, San<strong>of</strong>i Aventis,<br />
Vitry-sur-Seine, France, 2 INSERM U370, Paris, France,<br />
3 Safety Assessment, AstraZeneca, Cheshire, United<br />
Kingdom and 4 CITP, Harrogate, United Kingdom.<br />
#119 PROFILES OF GLOBAL GENE EXPRESSION IN<br />
IONIZING RADIATION-DAMAGED HUMAN<br />
DIPLOID FIBROBLASTS REVEAL<br />
SYNCHRONIZATION BEHIND THE G1<br />
CHECKPOINT. T. Zhou 1 , J. W. Chou 2 , D. A.<br />
Simpson 1 , Y. Zhou 1 , T. E. Mullen 1 , M. Medeiros 1 , P. R.<br />
Bushel 2 , R. S. Paules 2 , X. Yang 1 , P. Hurban 3 , E. K.<br />
Lobenh<strong>of</strong>er 3 and W. K. Kaufmann 1 . 1 Pathology & Lab.<br />
Medicine, University <strong>of</strong> North Carolina, Chapel Hill,<br />
NC, 2 National Institute <strong>of</strong> Environmental Health<br />
Science, Research Triangle Park, NC and 3 Paradigm<br />
Genetics, Research Triangle Park, NC.<br />
#120 EXPRESSION OF THE HELIX-LOOP-HELIX<br />
INHIBITOR OF DNA BINDING-1 (ID-1) GENE IS<br />
REGULATED BY RETINOIC ACID IN NORMAL<br />
HUMAN KERATINOCYTES. L. A. White and C. M.<br />
Villano. Biochemistry and Microbiology, Rutgers<br />
University, New Brunswick, NJ.<br />
#121 APPLICATION OF A CROSS-PLATFORM RNA<br />
STANDARD FOR ASSESSING MICROARRAY<br />
DATA COMPARABILITY. P. S. Pine 1 , B. A.<br />
Rosenzweig 1 , J. C. Fuscoe 2 , C. A. Afshari 3 , H. K.<br />
Hamadeh 3 , J. D. Retief 4 , Y. Turpaz 4 , E. Blomme 5 , R.<br />
Ciurlionis 5 , J. F. Waring 5 , R. S. Paules 6 , C. J. Tucker 6 ,<br />
T. L. Fare 7 , E. M. C<strong>of</strong>fey 7 , Y. He 7 , J. Collins 8 , K.<br />
Jarnagin 9 , S. Fujimoto 9 , G. L. Kiser 10 , T. Kaysser-<br />
Kranich 10 , F. D. Sistare 11 , J. Sina 11 and K. Thompson 1 .<br />
1 2 CDER, U.S. FDA, Silver Spring, MD, NCTR, U.S.<br />
FDA, Jefferson, AR, 3 Amgen Inc., Thousand Oaks, CA,<br />
4 5 Affymetrix Inc., Santa Clara, CA, Abbott<br />
Laboratories, Abbott Park, IL, 6 NIEHS, Research<br />
Triangle Park, NC, 7 Rosetta Inpharmatics, Seattle, WA,<br />
8 9 Agilent Technologies, Santa Clara, CA, Iconix<br />
Pharmaceuticals, Mountain View, CA, 10 GE Healthcare,<br />
Chandler, AZ and 11 Merck & Co. Inc., West Point, PA.<br />
#122 GENE EXPRESSION MODIFICATIONS IN A<br />
MOUSE EMPHYSEMA MODEL INDUCED BY<br />
ELASTASE. Q. Meng 1 , K. M. Waters 2 , J. M. Malard 2 ,<br />
K. Lee 1 and J. G. Pounds 2 . 1 Battelle <strong>Toxicology</strong><br />
Northwest, Richland, WA and 2 Pacific Northwest<br />
National Laboratories, Richland, WA.<br />
#123 TUMOR SUBTYPE CHEMOTHERAPEUTIC<br />
RESPONSES IN THE BREAST. K. Hoadley 1 , M. A.<br />
Troester 2 and C. M. Perou 1,2,3 . 1 Curriculum in Genetics<br />
and Molecular Biology, University <strong>of</strong> North Carolina,<br />
Chapel Hill, NC, 2 Lineberger Comprehensive Cancer<br />
Center, University <strong>of</strong> North Carolina, Chapel Hill, NC<br />
and 3 Department <strong>of</strong> Genetics, University <strong>of</strong> North<br />
Carolina, Chapel Hill, NC. Sponsor: J. Swenberg.<br />
#124 USE OF GENE EXPRESSION CHANGES IN<br />
CIRCULATING BLOOD CELLS TO MONITOR<br />
XENOESTROGEN EXPOSURE IN NEONATAL<br />
MICE. F. Lim, K. Antrobus, D. J. Moore, H. Tinwell, I.<br />
Kimber, J. Ashby, G. Orphanides and J. Moggs.<br />
Syngenta CTL, Macclesfield, Cheshire, United<br />
Kingdom.<br />
#125 COMPARISON OF WHOLE BLOOD GENE<br />
EXPRESSION PROFILES FROM THREE NON-<br />
HUMAN PRIMATE SPECIES AND HUMANS. C.<br />
S. Phillips and J. F. Dillman. Applied Pharmacology,<br />
USAMRICD, Aberdeen Proving Ground, MD. Sponsor:<br />
A. Sciuto.<br />
#126 THE BIOLOGY OF DRUG SIGNATURES. C.<br />
Pearson, R. Brennan, M. Fielden, B. Ganter, W. Hu, S.<br />
Tugendreich, A. Vladimirova and K. Kolaja. Iconix<br />
Pharmaceuticals, Inc., Mountain View, CA.<br />
#127 GENE EXPRESSION ANALYSIS OFFERS<br />
UNIQUE ADVANTAGES TO HISTOPATHOLOGY<br />
IN PREDICTION OF OVERALL LIVER<br />
CONDITION. A. N. Heinloth 1 , G. A. Boorman 2 and R.<br />
S. Paules 1 . 1 NCT, NIEHS, Research Triangle Park, NC<br />
and 2 ETP, NIEHS, Research Triangle Park, NC.<br />
58<br />
SOT’s 44 th Annual Meeting